Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |